tiprankstipranks
Vaccinex Inc (VCNX)
NASDAQ:VCNX
US Market

Vaccinex (VCNX) Stock Price & Analysis

278 Followers

VCNX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.43 - $100.97
Previous Close$4.8
Volume5.68K
Average Volume (3M)13.40K
Market Cap
$6.91M
Enterprise Value$5.55M
Total Cash (Recent Filing)$1.53M
Total Debt (Recent Filing)$247.00K
Price to Earnings (P/E)>-0.1
Beta1.03
May 13, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-64.40
Shares Outstanding1,231,602
10 Day Avg. Volume12,086
30 Day Avg. Volume13,402
Standard Deviation0.25
R-Squared0.03
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-2.57
Price to Sales (P/S)10.46
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.16
Enterprise Value/Gross Profit9.74
Enterprise Value/Ebitda-0.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

VCNX FAQ

What was Vaccinex Inc’s price range in the past 12 months?
Vaccinex Inc lowest stock price was $4.43 and its highest was $100.97 in the past 12 months.
    What is Vaccinex Inc’s market cap?
    Currently, no data Available
    When is Vaccinex Inc’s upcoming earnings report date?
    Vaccinex Inc’s upcoming earnings report date is May 13, 2024 which is in 16 days.
      How were Vaccinex Inc’s earnings last quarter?
      Vaccinex Inc released its earnings results on Apr 02, 2024. The company reported -$3.716 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.716.
        Is Vaccinex Inc overvalued?
        According to Wall Street analysts Vaccinex Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Vaccinex Inc pay dividends?
          Vaccinex Inc does not currently pay dividends.
          What is Vaccinex Inc’s EPS estimate?
          Vaccinex Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Vaccinex Inc have?
          Vaccinex Inc has 1,424,602 shares outstanding.
            What happened to Vaccinex Inc’s price movement after its last earnings report?
            Vaccinex Inc reported an EPS of -$3.716 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.602%.
              Which hedge fund is a major shareholder of Vaccinex Inc?
              Currently, no hedge funds are holding shares in VCNX
              ---

              Vaccinex Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -94.51%
              12-Months-Change

              Fundamentals

              Return on Equity
              -1405.34%
              Trailing 12-Months
              Asset Growth
              -54.48%
              Trailing 12-Months

              Company Description

              Vaccinex Inc

              Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Te firm focuses in the development of pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma and Huntington's disease. Its products pipeline include SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              vTv Therapeutics
              Verastem
              Viveve Medical
              Voyager Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis